7 papers in the library · 95 citations · publishing 2022-2025
Front Psychiatry October 24, 2025 Fares Qeadan, Ashlie McCunn, Benjamin Tingey et al.
Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study.
PLoS One 2024 Elena Argento, Tashia Petker, Jayesh Vig et al. 3 citations
This study explores therapists' perspectives on experiential learning, competencies, and training in ketamine-assisted therapy (KAT), a form of psychedelic-assisted therapy (PAT). We aim to understand how therapists' personal psychedelic experiences influence their self-perceived competency and therapeutic relationships regarding KAT. Licensed therapists from Numinus Wellness clinics in Canada...
Journal of Psychoactive Drugs 2024 Reid Robison, Madeline Brendle, Claire Moore et al.
This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions....
Journal of Pain and Symptom Management September 1, 2023 Benjamin R. Lewis, Eric L Garland, Kevin Byrne et al. 60 citations
Psilocybin-assisted psychotherapy shows promise in treating depression and existential distress in people with serious medical illness. However, its individual-based methodology poses challenges for scaling and resource availability. The HOPE trial (A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients with Cancer) is an Institutional Review Boards-approved open-label feasibility...
Frontiers in Neuroscience June 12, 2023 Elena Argento, Egiroh Omene, Alexandra Jaeger et al. 10 citations
Functional seizures, a primary subtype of functional neurological disorder (FND), are a known cause of serious neurological disability with an increasing awareness of their impact amongst the neuroscience community. Situated at the intersection of neurology and psychiatry, FND is characterized by a range of alterations in motor, sensory or cognitive performance, such as abnormal movements, limb...
Journal of Psychedelic Studies January 18, 2023 Benjamin R. Lewis, Kevin Byrne, John Hendrick et al. 22 citations
Abstract Background Psilocybin-assisted psychotherapy has demonstrated significant promise as a treatment for depression, anxiety, and existential distress associated with serious medical illness and has generally been employed on an individual basis, which presents challenges for scaling and resource availability. There are also compelling theoretical reasons to suggest that group-based...
BMC Psychiatry October 3, 2022 S. Ahuja, M. Brendle, Leo Smart et al.
Background Ketamine has emerged as a promising pharmacotherapy for depression and other mental illnesses, and the intramuscular (IM) administration of ketamine is now offered at many North American outpatient psychiatric clinics. However, a characterization of the outpatient population receiving IM ketamine treatment and an evaluation of the real-world depression, anxiety, and safety outcomes...